Primary cardiac sarcomas: Treatment strategies

Published:January 31, 2022DOI:



      Our multidisciplinary cardiac tumor team now has an experience of operating on 122 cases of primary cardiac sarcoma over a 23-year period. The purpose of this study is to present our short- and long-term outcomes for cardiac sarcoma.


      We performed a retrospective review of a prospectively collected Institutional Review Board–approved cardiac tumor database for cardiac sarcoma. Patient characteristics, surgical factors, and patient outcomes were analyzed. Perioperative data were collected from direct patient communication and all available medical records. The primary end point was all-cause mortality at 1, 3, and 5 years from the time of our surgery and 1, 3, and 5 years from the initial diagnosis. The secondary end point was all-cause mortality between the first and second halves of the study.


      From October 1998 to April 2021, we operated on 122 patients with a primary cardiac sarcoma. The mean age was 45.3 years old, and 52.5% were male. Tumors were most frequently found in the left atrium (40.2%) and right atrium (32.0%). The most common type of tumor histologically was an angiosarcoma (38.5%), followed by high-grade sarcoma (14.8%). Survival from initial diagnosis at 1, 3, and 5 years was 88.4%, 43.15%, and 27.8%, respectively. Survival from surgery at our institution at 1 and 3 years was 57.1% and 24.5%, respectively. When comparing outcomes from different time periods, we found no significant difference in survival between the previous era (1998-2011) and the current era (2011-2021).


      Management of these complex patients can show reasonable outcomes in centers with a multidisciplinary cardiac tumor team. Mortality has not improved with time and is likely related to the systemic nature of this disease.

      Graphical abstract

      Key Words

      Abbreviations and Acronyms:

      CI (confidence interval), CPB (cardiopulmonary bypass), IQR (interquartile range), PCS (primary cardiac sarcoma)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ramlawi B.
        • Leja M.J.
        • Abu Saleh W.K.
        • Al Jabbari O.
        • Benjamin R.
        • Ravi V.
        • et al.
        Surgical treatment of primary cardiac sarcomas: review of a single-institution experience.
        Ann Thorac Surg. 2016; 101: 698-702
        • Bakaeen F.G.
        • Jaroszewski D.E.
        • Rice D.C.
        • Walsh G.L.
        • Vaporciyan A.A.
        • Swisher S.S.
        • et al.
        Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era.
        J Thorac Cardiovasc Surg. 2009; 137: 1454-1460
        • Look Hong N.J.
        • Pandalai P.K.
        • Hornick J.L.
        • Shekar P.S.
        • Harmon D.C.
        • Chen Y.-L.
        • et al.
        Cardiac angiosarcoma management and outcomes: 20-year single-institution experience.
        Ann Surg Oncol. 2012; 19: 2707-2715
        • Blackmon S.H.
        • Reardon M.J.
        Surgical treatment of primary cardiac sarcomas.
        Tex Heart Inst J. 2009; 36: 451-452
        • Agaimy A.
        • Rosch J.
        • Weyand M.
        • Strecker T.
        Primary and metastatic cardiac sarcomas: a 12-year experience at a German heart center.
        Int J Clin Exp Pathol. 2012; 5: 928-938
        • Palazzuoli A.
        • Beltrami M.
        • Sabini A.
        • Magnolfi A.
        • Bucciarelli-Ducci C.
        [Incidental myocardial mass: differential diagnosis, clinical approach and literature review].
        G Ital Cardiol (Rome). 2012; 13: 765-768
        • Yin K.
        • Luo R.
        • Wei Y.
        • Wang F.
        • Zhang Y.
        • Karlson K.J.
        • et al.
        Survival outcomes in patients with primary cardiac sarcoma in the United States.
        J Thorac Cardiovasc Surg. 2021; 162: 107-115.e2
        • Kim M.P.
        • Correa A.M.
        • Blackmon S.
        • Quiroga-Garza G.
        • Weilbaecher D.
        • Bruckner B.
        • et al.
        Outcomes after right-side heart sarcoma resection.
        Ann Thorac Surg. 2011; 91: 770-776
        • Ramlawi B.
        • Al-Jabbari O.
        • Blau L.N.
        • Davies M.G.
        • Bruckner B.A.
        • Blackmon S.H.
        • et al.
        Autotransplantation for the resection of complex left heart tumors.
        Ann Thorac Surg. 2014; 98: 863-868
        • StataCorp
        • Stata lasso
        Stata Reference Manual: Release 16.
        Stata Press, College Station, TX2019
        • Wainwright M.J.
        • Tibshirani R.J.
        • Hastie T.
        Statistical Learning With Sparsity: The Lasso and Generalizations.
        Chapman & Hall/CRC, Boca Raton, FL2015
        • Travis W.D.
        • Brambilla E.
        • Burke A.P.
        • Marx A.
        • Nicholson A.G.
        Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart.
        J Thorac Oncol. 2015; 10: 1240-1242
        • Yanagawa B.
        • Mazine A.
        • Chan E.Y.
        • Barker C.M.
        • Gritti M.
        • Reul R.M.
        • et al.
        Surgery for tumors of the heart.
        Semin Thorac Cardiovasc Surg. 2018; 30: 385-397
        • Blackmon S.H.
        • Rice D.C.
        • Correa A.M.
        • Mehran R.
        • Putnam J.B.
        • Smythe W.R.
        • et al.
        Management of primary pulmonary artery sarcomas.
        Ann Thorac Surg. 2009; 87: 977-984
        • Lestuzzi C.
        • Reardon M.J.
        Primary cardiac malignancies: the need for a multidisciplinary approach and the role of the cardio-oncologist.
        J Am Coll Cardiol. 2020; 75: 2348-2351
        • Kassi M.
        • Polsani V.
        • Schutt R.C.
        • Wong S.
        • Nabi F.
        • Reardon M.J.
        • et al.
        Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging.
        J Thorac Cardiovasc Surg. 2019; 157: 1912-1922.e2